Literature DB >> 21964177

73-year-old man with increasing abdominal girth and dyspnea.

Sara L Reppert1, Christopher M Wittich.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21964177      PMCID： PMC3184030          DOI： 10.4065/mcp.2011.0318

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  9 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 2.  Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.

Authors:  Keith G Tolman; Vivian Fonseca; Anthony Dalpiaz; Meng H Tan
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

Review 3.  Ascites: diagnosis and management.

Authors:  Wei Hou; Arun J Sanyal
Journal:  Med Clin North Am       Date:  2009-07       Impact factor: 5.456

Review 4.  Biochemical analysis of ascitic (peritoneal) fluid: what should we measure?

Authors:  A C Tarn; R Lapworth
Journal:  Ann Clin Biochem       Date:  2010-07-01       Impact factor: 2.057

Review 5.  When and how to evaluate mildly elevated liver enzymes in apparently healthy patients.

Authors:  George Aragon; Zobair M Younossi
Journal:  Cleve Clin J Med       Date:  2010-03       Impact factor: 2.321

Review 6.  Novel treatment modalities for nonalcoholic steatohepatitis.

Authors:  Sanjaya K Satapathy; Arun J Sanyal
Journal:  Trends Endocrinol Metab       Date:  2010-09-27       Impact factor: 12.015

Review 7.  Wilson disease.

Authors:  Dominik Huster
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-10       Impact factor: 3.043

Review 8.  Nonalcoholic fatty liver disease.

Authors:  Marcin Krawczyk; Leonilde Bonfrate; Piero Portincasa
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-10       Impact factor: 3.043

Review 9.  Nonalcoholic fatty liver disease.

Authors:  M C Hjelkrem; D M Torres; S A Harrison
Journal:  Minerva Med       Date:  2008-12       Impact factor: 4.806
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.